´╗┐
 Return to QS135 Overview

Preterm labour and birth [QS135]

Measuring the use of this guidance

Statement: 4

Women between 26+0 and 29+6 weeks of pregnancy who are in suspected preterm labour are offered tocolysis and maternal corticosteroids.

Quality standard measure: Proportion of women between 26+0 and 29+6 weeks of pregnancy in suspected preterm labour who receive maternal corticosteroids.
What was measured: Proportion of mothers who delivered their babies before 34 weeks who received any dose of antenatal steroids.
Data collection end: December 2016
86%
Number that met the criteria: 16317 / 18947
Data collection end: December 2017
87%
Number that met the criteria: 16550 / 18965
Area covered: England and Wales
Source: Royal College of Paediatrics and Child Health. National Neonatal Audit Programme.

Quality standard measure: Proportion of women between 26+0 and 29+6 weeks of pregnancy in suspected preterm labour who receive maternal corticosteroids.
What was measured: Proportion of mothers who delivered their babies before 34 weeks who received any dose of antenatal steroids.
Data collection end: December 2018
90.5%
Area covered: England and Wales
Source: Royal College of Paediatrics and Child Health. National Neonatal Audit Programme.


Statement: 6

Women between 24+0 and 29+6 weeks of pregnancy who are in established preterm labour or having a planned preterm birth within 24 hours are offered magnesium sulfate.

Quality standard measure: Proportion of women between 24+0 and 29+6 weeks of pregnancy in established preterm labour who receive magnesium sulfate.
What was measured: Proportion of mothers who delivered their babies before 30 weeks who received magnesium sulphate 24 hours prior to delivery.
Data collection end: December 2018
72%
Area covered: England and Wales
Source: Royal College of Paediatrics and Child Health. National Neonatal Audit Programme.



 Return to QS135 Overview